X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/04/2857730/0/en/Ovid-Therapeutics-to-Present-at-the-23rd-Annual-Needham-Virtual-Healthcare-Conference.html
https://endpts.com/ovid-asks-uspto-to-review-marinus-patent-around-treatment-of-serious-seizure-condition/
https://www.globenewswire.com/news-release/2024/03/08/2843091/0/en/Ovid-Therapeutics-Reports-Business-Updates-Fourth-Quarter-and-Full-Year-2023-Financial-Results.html
https://www.globenewswire.com//news-release/2024/02/28/2836903/0/en/Ovid-Therapeutics-to-Present-at-the-TD-Cowen-44th-Annual-Health-Care-Conference.html
https://www.globenewswire.com//news-release/2024/02/06/2824229/0/en/Ovid-Therapeutics-to-Present-at-the-Oppenheimer-34th-Annual-Healthcare-Life-Sciences-Conference.html
https://www.globenewswire.com//news-release/2023/12/01/2789250/0/en/Ovid-Therapeutics-to-Present-Five-Abstracts-Supporting-its-Epilepsy-Programs-at-the-77th-American-Epilepsy-Society-Annual-Meeting-2023.html
https://www.globenewswire.com//news-release/2023/11/03/2773136/0/en/Ovid-Therapeutics-Reports-Third-Quarter-2023-Financial-Results-and-Corporate-Updates.html
https://www.fiercebiotech.com/biotech/ovid-extends-cash-runway-selling-part-royalty-rights-takeda-partnered-seizure-drug
https://www.globenewswire.com//news-release/2023/10/18/2762278/0/en/Ovid-Therapeutics-and-Ligand-Pharmaceuticals-Enter-into-a-30-Million-Agreement-for-a-13-Interest-in-Soticlestat-Royalties-and-Milestones-Extending-Ovid-s-Cash-Runway-into-2026.html
Market Place
Share 
